Trial record 1 of 1 for:    NCT00526838
Previous Study | Return to List | Next Study

Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies

This study has been terminated.
(Sponsor decision)
Information provided by (Responsible Party):
Exelixis Identifier:
First received: September 6, 2007
Last updated: August 19, 2015
Last verified: August 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2010
  Primary Completion Date: December 2010 (Final data collection date for primary outcome measure)